Brief: Dyadic’S C1 Platform Selected By The Vaccine And Immunotherapy Center (“VIC”) At Massachusetts General Hospital As Part Of Vic’S $5.88 Million Award By U.S. DoD

Dyadic International

05/10/2023 13:36

Oct 5 (Reuters) - Dyadic International Inc  DYAI.O :
    * DYADIC’S C1 PLATFORM SELECTED BY THE VACCINE AND
IMMUNOTHERAPY
CENTER (“VIC”) AT MASSACHUSETTS GENERAL HOSPITAL AS PART OF
VIC’S $5.88 MILLION AWARD BY U.S. DOD TO DEVELOP A
SELF-ASSEMBLING VACCINE (SAV) PLATFORM FOR RAPID PRODUCTION OF
PROPHYLACTIC VACCINES FOR INFECTIOUS DISEASES

Source text for Eikon:  ID:nGNX2YnTdL 
Further company coverage:  DYAI.O 

 ((Reuters.Briefs@thomsonreuters.com;))